Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000–2009

References

• Jobsen J, van der Palen J, Riemersma S, Heijmans H, Ong F, Struikmans H. Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys [Internet]. Elsevier Inc. 2014;89:1006–14.
   PubMed Web of Science ®Google Scholar
• Kaufmann M, von Minckwitz G, Bergh J, Conte P-F, Darby S, Eiermann W, et al. Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades. Arch Gynecol Obstet [Internet] 2013;288:1203–12.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, van ’T Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005;5:591–602.
   PubMed Web of Science ®Google Scholar
• Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan Sa, Horton J, et al. Society of surgical oncology-american society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and ii invasive breast cancer. Ann Surg Oncol [Internet]. Elsevier Inc 2014;88:553–64.
   Web of Science ®Google Scholar
• Houssami N, Macaskill P, Marinovich ML, Morrow M. The Association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol [Internet] 2014;21:717–30.
   PubMed Web of Science ®Google Scholar
• Poortmans P, Aznar M, Bartelink H. Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes. Semin Radiat Oncol 2012;22:29–39.
   PubMed Web of Science ®Google Scholar
• Møller S, Jensen M-B, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506–24.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Christensen JJ. Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience. Acta Oncol 2008;47:639–53.
   PubMed Web of Science ®Google Scholar
• Friis E, Galatius H, Garne JP. Organized nation-wide implementation of sentinel lymph node biopsy in Denmark. Acta Oncol 2008;47:556–60.
   PubMed Web of Science ®Google Scholar
• Sanpaolo P, Barbieri V, Genovesi D. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Eur J Surg Oncol 2011;37:876–82.
   PubMed Web of Science ®Google Scholar
• Kunkler IH, Kerr GR, Thomas JS, Jack WJL, Bartlett JMS, Pedersen HC, et al. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up. Int J Radiat Oncol Biol Phys 2012;83:829–38.
   PubMed Web of Science ®Google Scholar
• Mansell J, Monypenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM, et al. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat 2009;117:91–8.
   PubMed Web of Science ®Google Scholar
• Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 2013;381:805–16.
   PubMed Web of Science ®Google Scholar
• Rakha Ea, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 2010;12:207
   PubMed Web of Science ®Google Scholar
• Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 2001;19:1688–97.
   PubMed Web of Science ®Google Scholar
• Jobsen JJ, Van Der Palen J, Ong F, Meerwaldt JH. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Acta Oncol 2007;46:172–80.
   PubMed Web of Science ®Google Scholar
• Jobsen J, Vanderpalen J, Ong F, Meerwaldt J. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol 2003;57:724–31.
   PubMed Web of Science ®Google Scholar
• Lupe K, Truong PT, Alexander C, Lesperance M, Speers C, Tyldesley S. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Int J Radiat Oncol Biol Phys 2011;18:561–8.
   Web of Science ®Google Scholar
• Dinshaw KA, Budrukkar AN, Chinoy RF, Sarin R, Badwe R, Hawaldar R, et al. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2005;63:1132–41.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687–717.
   PubMed Web of Science ®Google Scholar
• Lash TL, Fox MP, Westrup JL, Fink AK, Silliman Ra. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006;99:215–20.
   PubMed Web of Science ®Google Scholar
• Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 2010;28:4120–8.
   PubMed Web of Science ®Google Scholar
• Bodilsen A, Bjerre K, Offersen BV, Vahl P, Amby N, Dixon JM, et al. Importance of margin width in breast conserving treatment of early breast cancer; a Danish Breast Cancer Cooperative Group study of 11,900 women. Unpubl data.
   Google Scholar
• Bartelink H, Horiot J-C, Poortmans P, Struikmans H, Van den Bogaert WF, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. English J 2001;345:1378–87.
   Google Scholar
• Bartelink H, Horiot J-C, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007;25:3259–65.
   PubMed Web of Science ®Google Scholar